EFFECT OF HCV THERAPY ON IMMUNOLOGICAL HOMEOSTASIS IN HIV/HCV CO-INFECTED PATIENTS

被引：0
|
作者：
Airoldi, M. [1 ]
Nasta, P. [2 ]
Maggiolo, F. [3 ]
Di Gianbenedetto, S. [4 ]
Ladisa, N. [5 ]
Gatti, F. [2 ]
Suter, F. [3 ]
Fabbiani, M. [4 ]
Bandera, A. [1 ]
Gori, A. [1 ]
机构：
[1] Univ Milano Bicocca, San Gerardo Hosp, Div Infect Dis, Monza, Italy
[2] Univ Brescia, Inst Infect & Trop Dis, Brescia, Italy
[3] Osped Riuniti Bergamo, USC Malattie Infett, I-24100 Bergamo, Italy
[4] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, Rome, Italy
[5] Univ Bari, Inst Infect Dis, Bari, Italy
来源：
INFECTION | 2011年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [1] MicroRNAs Profiling in HIV, HCV, and HIV/HCV Co-Infected Patients
    Moghoofei, Mohsen
    Najafipour, Sohrab
    Mostafaei, Shayan
    Tavakoli, Ahmad
    Bokharaei-Salim, Farah
    Ghorbani, Saied
    Javanmard, Davod
    Ghaffari, Hadi
    Monavari, Seyed Hamidreza
    [J]. CURRENT HIV RESEARCH, 2021, 19 (01) : 27 - 34
  • [2] Effect of mono/dual antiretroviral therapy on HCV and HIV suppression during HCV treatment in HIV/HCV co-infected patients
    Martin-Carbonero, Luz
    Dominguez, Lourdes
    Bailon, Lucia
    Torres, Rafael
    Rubio, Rafael
    Ron, Raquel
    Rico, Mikel
    Jimenez-Nacher, Inmaculada
    Moreno, Francisco
    Gonzalez, Juan
    Pulido, Federico
    Montes, Marisa
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [3] Combination therapy recommended for patients co-infected with HIV and HCV
    不详
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (09) : 489 - 489
  • [4] Inflammatory cells and apoptosis in HCV and co-infected HCV/HIV patients
    Petrovic, L.
    Rohan, S.
    Hayek, E.
    [J]. LIVER INTERNATIONAL, 2006, 26 : 74 - 74
  • [5] Comparison of therapeutic results on HCV and HCV/HIV co-infected patients
    Serra, J. E.
    Guzman, D.
    Velez, J.
    Pinto, P.
    Marques, N. M.
    da Cunha, J. G. Saraiva
    Melico-Silvestre, A.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S144 - S144
  • [6] Prevalence of risk factors for HCV transmission in HIV infected and HIV/HCV co-infected patients
    Bollepalli, S
    Mahthieson, K
    Post, J
    Hillier, A
    Nadir, A
    [J]. HEPATOLOGY, 2005, 42 (04) : 423A - 423A
  • [7] Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients
    Sherman, Kenneth E.
    Guedj, Jeremie
    Shata, Mohamed Tarek
    Blackard, Jason T.
    Rouster, Susan D.
    Castro, Mario
    Feinberg, Judith
    Sterling, Richard K.
    Goodman, Zachary
    Aronow, Bruce J.
    Perelson, Alan S.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (246)
  • [8] Long term immunological perturbations post DAA therapy in chronic HCV/HIV co-infected patients
    Moretti, Sonia
    Mancini, Flavia
    Borsetti, Alessandra
    [J]. BIOCELL, 2022, 46 (12) : 2695 - 2699
  • [9] Sofosbuvir and ledipasvir for HIV/HCV co-infected patients
    Rosenthal, Elana S.
    Kottilil, Shyam
    Polis, Michael A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (05) : 743 - 749
  • [10] Survival in HCV/HIV co-infected patients.
    Hassanein, TI
    Aronson, N
    Oliver, DL
    Barber, E
    Hilsabeck, RC
    Chatfield, E
    Stewart, M
    Mathews, C
    [J]. HEPATOLOGY, 2001, 34 (04) : 232A - 232A
12345